由河南省肿瘤医院中西医结合专家邵梦扬教授主持研制成功的生白宝口服液,最近由中外合资郑州东方药业有限公司投入批量生产。这种特效药物以黄芪、淫羊藿为主要成份,经实验表明,能够促进骨髓造血干细胞的增殖,具有补肾填精、益气健脾、养血生血的功效。适用于癌症病人化疗和放疗所致的白 Prof. Shao Mengyang, an expert in Integrative Medicine of Henan Province Tumor Hospital, presided over the successful development of Shengbaibao oral liquid, which was recently put into mass production by Sino-foreign joint venture Zhengzhou Oriental Pharmaceutical Co., Ltd. The special effects of this drug are Astragalus membranaceus and Epimedium, which have been shown to be able to promote the proliferation of bone marrow hematopoietic stem cells and have the efficacy of tonifying the kidney, filling essence, strengthening spleen, nourishing blood and boosting blood. Suitable for cancer patients caused by chemotherapy and radiotherapy caused by white